Lepu Biopharma Co (HKSE:02157) LT-Debt-to-Total-Asset : 0.10 (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Lepu Biopharma Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Lepu Biopharma Co's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.10.

Lepu Biopharma Co's long-term debt to total assets ratio declined from Jun. 2023 (0.12) to Jun. 2024 (0.10). It may suggest that Lepu Biopharma Co is progressively becoming less dependent on debt to grow their business.

Lepu Biopharma Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Lepu Biopharma Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lepu Biopharma Co LT-Debt-to-Total-Asset Chart

Lepu Biopharma Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

0.11

0.08

0.12

Lepu Biopharma Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial				0.10	0.12	0.12	0.12	0.10

Lepu Biopharma Co LT-Debt-to-Total-Asset Calculation

Lepu Biopharma Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	310.834	/	2607.904
	=	0.12

Lepu Biopharma Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )	/	Total Assets (Q: Jun. 2024 )
	=	267.845	/	2627.852
	=	0.10

Lepu Biopharma Co (HKSE:02157) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Lepu Biopharma Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Lepu Biopharma Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Lepu Biopharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lepu Biopharma Co Ltd (HKSE:02157) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 651, Lianheng Road, Minhang District, Shanghai, CHN, 201612

Website

https://www.lepubiopharma.com

Lepu Biopharma Co Ltd is a biopharmaceutical company focusing on oncology therapeutics and has one operating segment. The Group is principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The majority operating entity of the Group is domiciled in the PRC. The company has established an integrated end-to-end platform across drug discovery, clinical development, CMC, and GMP-compliant manufacturing, encompassing all critical functions of the biopharmaceutical value chain.

Executives

Pu Zhongjie	2201 Interest of corporation controlled by you
Hu Chaohong	2201 Interest of corporation controlled by you
Pu Jue	2201 Interest of corporation controlled by you
Hao Chunmei	2202 Interest of your spouse
Su Rongyu	2101 Beneficial owner
Miracogen Inc.	2201 Interest of corporation controlled by you
Miracogen Limited	2101 Beneficial owner
Cereblue Limited	2201 Interest of corporation controlled by you
Bei Jing Hou De Yi Min Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Ning Bo Hou De Yi Min Xin Xi Ke Ji You Xian Gong Si	2101 Beneficial owner
Le Pu Bei Jing Yi Liao Qi Xie Gu Fen You Xian Gong Si	2101 Beneficial owner
Lv Yuan Shang Hai Ke Ji You Xian Gong Si	2101 Beneficial owner

Lepu Biopharma Co Headlines

No Headlines